Benzinga’s Top Downgrades (KMB, MITI, CAN, CFX, KR, MDAS)

Kimberly-Clark Corporation (NYSE: KMB) has declined 1.43% to $63.98 in the morning session after Barclays downgraded KMB to from Equal-weight to Underweight and has lower the price target to $66 from $68.

Micromet Inc. (NASDAQ: MITI) fell 1.07% to $6.48 after Roth Capital downgraded Micromet from Buy to Hold with a price target of $7. The 52-week trading range for MITI is $2.25 - $8.48.

Accenture Plc (NYSE: ACN) has declined 2.01% to $42.01 after Kaufman Bros. downgraded Accenture from Buy to Hold, but raised the price target to $43 from $41. So far in 2009, CAN has gained over 28%.

Colfax Corporation (NYSE: CFX) has moved down 4.18% to $12.83 after Janney Montgomery downgraded Colfax from Buy to Neutral. The 52-week trading range for CFX is $5.33 - $13.91.

The Kroger Co. (NYSE: KR) fell 0.65% to $20 after UBS downgrades Kroger from Buy to Neutral and Price target has been lowered from $30 to $22.So far this year, KR is down over 24%.

MedAssets, Inc. (NASDAQ: MDAS) declined 5.77% to $18.78. Today, Baird downgraded MDAS Outperform to Neutral.. The 52 week trading range for MDAS is $11.05 - $24.74.